Abhinandan NANDRAJOG, Camille MENIER and Eva MARTIN join Mint as PhD students
Eva Martin obtained her master's degree in cellular biology, specializing in "Research in Biology and Health" during her second year. In the first year of her master's program, she completed an internship at the CRAN laboratory in Nancy, focusing on the study of in vitro withdrawal effects on chemotherapy response in breast cancer cells, particularly applied to spheroids. In her second year, she joined the MiNT Laboratory for an internship, where she worked on 3D models to evaluate the role of the Endothelial-to-Mesenchymal Transition in the response to treatments for Non-Small Cell Lung Carcinoma (NSCLC).
Eva is currently pursuing her Ph.D. at the MiNT Laboratory, under the supervision of Pr Nicolas Clere. Her research focuses on the study of the Endothelial-to-Mesenchymal Transition, as well as the STRO-MIR project, which aims to identify non-coding miRNAs from the tumor stroma to enhance the effectiveness of NSCLC treatments.
Camille Menier studied pharmacy at the University of Rennes. She specialized in galenics during her 6th year, obtaining a master's degree in industrial galenics at the University of Lille. During her 5th year, she was able to complete an internship on the development of biomimetic nanomedicines for the treatment of gliobastoma at the LCPO in Bordeaux. She joined the MINT laboratory for her final year internship and is now starting her Ph.D. under the supervision of Dr. Elise Lepeltier. Her research focuses on the development of nebulized self-assemblies for the treatment of lung cancer.
Abhinandan Nandrajog obtained his Bachelor’s of Pharmacy from Panjab University, Chandigarh in India and holds an Erasmus Mundus Joint Master’s degree in Nanomedicine. He is now doing his doctoral degree from University of Angers, under the supervision of Dr. Guillaume Bastiat. His project is focused on developing a preventive strategy for intimal hyperplasia, a prevalent pathology following vascular procedures, with no satisfactory treatment so far.obtained an . He is currently pursuing his Ph.D. at the MiNT Laboratory, under the supervision of Dr Guillaume Bastiat. His research focuses on the prevention of intimal hyperplasia.
